Back to Journals » ClinicoEconomics and Outcomes Research
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
Editor-in-Chief: Professor Giorgio Colombo
An international, peer-reviewed open-access journal focusing on Health Technology Assessment, Pharmacoeconomics and Outcomes Research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. The economic impact of health policy and health systems organization also constitute important areas of coverage.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (947)
- Volume 17, 2025 (38)
- Volume 16, 2024 (62)
- Volume 15, 2023 (67)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Latest articles:
- 5 records -
Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from Italy
Perrone V, Leogrande M, Giacomini E, Cappuccilli M, Degli Esposti L
ClinicoEconomics and Outcomes Research 2025, 17:495-505
Published Date: 19 July 2025
Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand
Permsuwan U, Leemasawat K, Arunmanakul P
ClinicoEconomics and Outcomes Research 2025, 17:485-494
Published Date: 16 July 2025
Evaluating the Economic Impact of Diabetes Mellitus: A Hospital-Centric Cost Analysis in Hail, Saudi Arabia
Alshammari AM, Elnaem MH, Ong SC
ClinicoEconomics and Outcomes Research 2025, 17:473-484
Published Date: 15 July 2025
Comparative Cost Analysis for Direct Medical Costs of Protocol Administration of Non-Small Cell Lung Cancer Treatment Regimens in Curative Intent: A Micro-Costing Study in Jordan
Madae’en SS, Salem AA, Ararawi NS, Ramzi EJ, Aloueedat RF, Saabenh AM, Allouzi DA, Abuoudeh RH, Hnaif OE, Musa LM, Alshdaifat SH, Al-Tanashat AJ, Almasa’afeh HY, Abuallaban SM
ClinicoEconomics and Outcomes Research 2025, 17:455-471
Published Date: 12 July 2025
Medicare Savings for Seizure Drugs by Adopting the Mark Cuban Cost Plus Drug Company Model
Smith T, Young A, O’Brien C, Duncan J, Rashid M, Magee T, Fitzgerald K, Vassar M
ClinicoEconomics and Outcomes Research 2025, 17:447-453
Published Date: 18 June 2025